Ethema Health (OTCMKTS:GRST – Get Free Report) and CareDx (NASDAQ:CDNA – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability and risk.
Volatility and Risk
Ethema Health has a beta of 0.83, suggesting that its share price is 17% less volatile than the S&P 500. Comparatively, CareDx has a beta of 2.43, suggesting that its share price is 143% more volatile than the S&P 500.
Profitability
This table compares Ethema Health and CareDx’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Ethema Health | -11.61% | N/A | -7.48% |
| CareDx | -2.01% | -2.65% | -1.96% |
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Ethema Health | $18.76 million | 0.00 | -$2.18 million | N/A | N/A |
| CareDx | $379.80 million | 3.97 | -$21.35 million | ($0.16) | -182.44 |
Ethema Health has higher earnings, but lower revenue than CareDx.
Analyst Ratings
This is a breakdown of recent ratings and price targets for Ethema Health and CareDx, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Ethema Health | 0 | 0 | 0 | 0 | 0.00 |
| CareDx | 1 | 4 | 1 | 0 | 2.00 |
CareDx has a consensus price target of $25.00, indicating a potential downside of 14.35%. Given Ethema Health’s higher possible upside, equities research analysts clearly believe Ethema Health is more favorable than CareDx.
Summary
CareDx beats Ethema Health on 6 of the 9 factors compared between the two stocks.
About Ethema Health
Ethema Health Corporation operates behavioral healthcare space specifically in the treatment of substance use disorders. It offers rehabilitation services. The company was formerly known as GreeneStone Healthcare Corporation and changed its name to Ethema Health Corporation in April 2017. Ethema Health Corporation is based in West Palm Beach, Florida.
About CareDx
CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
Receive News & Ratings for Ethema Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ethema Health and related companies with MarketBeat.com's FREE daily email newsletter.
